drugset / Trial / NCT02606214
A Multiple Ascending Dose Study With a Dose Formulation Comparison Cohort to Evaluate the Safety, Tolerability, and Pharmacokinetics of TBA-354 in Healthy Adult Subjects
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of the study is to evaluate the safety and tolerability of multiple doses of TBA-354 in healthy subjects.
Timeline
- Start
- 2015-11
- Primary completion
- 2015-12
- Completion
- 2016-12
Outcome
Outcome not reported
Stopped: “Clinical Hold from FDA”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TBA-354 | Small molecule | 50 mg | Oral |
| Subject | TBA-354 | Small molecule | 100 mg | Oral |
| Subject | TBA-354 | Small molecule | 200 mg | Oral |